DUBLIN--(BUSINESS WIRE)--The "Autoimmune Disease Diagnosis Market by Product (Consumables, Assay Kits, Instruments), Test Type (Inflammatory Markers, Routine Laboratory Tests), Disease (RA, SLE, Thyroiditis, Scleroderma), End User (Hospitals, Clinical Labs) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global autoimmune disease diagnosis market size is projected to reach USD 6.3 billion by 2025 from USD 4.1 billion in 2020, at a CAGR of 8.9%.
Growth in this industry is driven by the rising incidence of chronic diseases and the increasing demand for autoimmune disease diagnosis due to their cost-effectiveness. On the other hand, complexities in manufacturing restraining the market.
The consumables & assay kits segment is anticipated to grow at the fastest growth rate during the forecast period.
The autoimmune disease diagnosis market by product is categorized into consumables & assay kits and instruments. The consumables & assay kits segment is expected to register the highest CAGR during the forecast period. The growth of this segment is driven mainly by the increasing number of product launches/approvals, rising incidences of autoimmune diseases.
The routine laboratory tests segment is estimated to grow at a rapid rate during the analysis period.
Based on the test type, the autoimmune disease diagnosis market is segmented into routine laboratory tests, inflammatory markers, autoantibodies & immunologic tests, and other tests. The routine laboratory tests segment is expected to remain the fastest-growing segment of the global market during the autoimmune disease diagnosis period. The increasing number of regular health checkups, growing government initiatives to promote the importance of early disease diagnosis, are driving growth.
Asia Pacific is estimated to register the highest CAGR during the study period.
Geographically, the autoimmune disease diagnosis market is dominated by Europe and followed by North America in 2019. However, the Asia Pacific region is estimated to grow at the fastest rate during forecast to period. The rising aging population, coupled with the massive demand for effective diagnosis of autoimmune diseases, will drive the market in the region over the forecast period.
Market Dynamics
Drivers
- High Incidence and Prevalence of Autoimmune Diseases
- Increasing Awareness About Autoimmune Diseases
- Growth in the Number of Research Activities on Autoimmune Diseases
Restraints
- High Capital Requirements
Opportunities
- Use of Biosensors for Autoimmune Disease Diagnosis
Trends
- Growth in the Number of Reagent Rental Agreements
Companies Profiled
- Thermo Fisher Scientific
- Siemens
- Abbott
- Danaher
- Bio-Rad Laboratories
- Grifols
- Trinity Biotech
- Werfen
- Hycor Biomedical
- Euroimmun
- Oncimmune
- HTG Molecular Diagnostics, Inc.
- Seramun Diagnostica GmbH
- Exagen Inc.
- Cambridge Life Sciences Limited
- A. Menarini Diagnostics S.R.L
- Orgentec Diagnostika
- Kronus
- Erba Group
- Aesku.Group GmbH & Co. Kg
For more information about this report visit https://www.researchandmarkets.com/r/48t6uu
